Using atomic-level imaging, Paul Seidler, UCLA, looks at how tau protein creates tangles in Alzheimer’s—and how to stop it with well-designed drugs. The work is supported by a partnership between BrightFocus and Alzheimer’s Los Angeles.
Funded in part by BrightFocus’ Macular Degeneration Research program, Allen Taylor, MD, and his colleagues at Tufts University are studying how dietary patterns can affect the eyes and one’s risk of macular degeneration.
A groundbreaking study is providing a more complete understanding of how Alzheimer’s disease worsens in the brain, helping to unite what had been two separate schools of thought on the causes of Alzheimer’s, and accelerating future research into effective treatments and cure.
Two scientists at the University of Florida, supported by a grant from BrightFocus’ Macular Degeneration Research program, have uncovered some tantalizing clues that a drug previously investigated to protect against nerve damage during cancer treatment could offer some protection for the nerve cells of the eye in late-stage dry age-related macular degeneration.
Kip Connor, PhD, with funding from Macular Degeneration Research (MDR), has lead a team of experts to discover an important role of immune cells that regulate, and could potentially stop, abnormal blood vessel growth in advanced age-related macular degeneration (AMD).
September 5, 2017
Donate to Cure Brain and Eye Diseases
Help end Alzheimer's, Macular Degeneration, and Glaucoma